Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chie Watanabe

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Internal Medicine (Tokyo, Japan)|July 12, 2019
Successful Control of Dasatinib-related Chylothorax by the Japanese Herbal Medicine "Goreisan"Hisashi Sasaki, Yoshifumi Kimizuka, Hiraku Ogata, et al.
Clinical Breast Cancer|December 3, 2014
BRCAness predicts resistance to taxane-containing regimens in triple negative breast cancer during neoadjuvant chemotherapySadako Akashi-Tanaka, Chie Watanabe, Tomoko Takamaru, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 28, 2006
[A case of primary duodenal cancer near the papilla of Vater which had initial symptoms of obstructive jaundice]Takeharu Kameyama, Yuichi Yasunaga, Takashi Kizu, et al.
Journal of Human Genetics|November 28, 2017
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in JapanMasami Arai, Shiro Yokoyama, Chie Watanabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphomaYasuhito Terui, Yuji Mishima, Natsuhiko Sugimura, et al.
Breast Cancer (Tokyo, Japan)|December 3, 2023
Annual report of the Japanese Breast Cancer Registry for 2019Minoru Miyashita, Hiraku Kumamaru, Naoki Niikura, et al.
Clinical Breast Cancer|March 20, 2016
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast CancerKatsutoshi Enokido, Chie Watanabe, Seigo Nakamura, et al.
Journal of Human Genetics|February 2, 2018
Correction: Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in JapanMasami Arai, Shiro Yokoyama, Chie Watanabe, et al.
Breast Cancer (Tokyo, Japan)|January 5, 2024
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in JapanYasuaki Sagara, Hiraku Kumamaru, Naoki Niikura, et al.
Breast Cancer (Tokyo, Japan)|February 6, 2024
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer RegistryTakayuki Iwamoto, Hiraku Kumamaru, Naoki Niikura, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Internal Medicine (Tokyo, Japan)|July 12, 2019
Successful Control of Dasatinib-related Chylothorax by the Japanese Herbal Medicine "Goreisan"Hisashi Sasaki, Yoshifumi Kimizuka, Hiraku Ogata, et al.
Clinical Breast Cancer|December 3, 2014
BRCAness predicts resistance to taxane-containing regimens in triple negative breast cancer during neoadjuvant chemotherapySadako Akashi-Tanaka, Chie Watanabe, Tomoko Takamaru, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 28, 2006
[A case of primary duodenal cancer near the papilla of Vater which had initial symptoms of obstructive jaundice]Takeharu Kameyama, Yuichi Yasunaga, Takashi Kizu, et al.
Journal of Human Genetics|November 28, 2017
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in JapanMasami Arai, Shiro Yokoyama, Chie Watanabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphomaYasuhito Terui, Yuji Mishima, Natsuhiko Sugimura, et al.
Breast Cancer (Tokyo, Japan)|December 3, 2023
Annual report of the Japanese Breast Cancer Registry for 2019Minoru Miyashita, Hiraku Kumamaru, Naoki Niikura, et al.
Clinical Breast Cancer|March 20, 2016
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast CancerKatsutoshi Enokido, Chie Watanabe, Seigo Nakamura, et al.
Journal of Human Genetics|February 2, 2018
Correction: Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in JapanMasami Arai, Shiro Yokoyama, Chie Watanabe, et al.
Breast Cancer (Tokyo, Japan)|January 5, 2024
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in JapanYasuaki Sagara, Hiraku Kumamaru, Naoki Niikura, et al.
Breast Cancer (Tokyo, Japan)|February 6, 2024
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer RegistryTakayuki Iwamoto, Hiraku Kumamaru, Naoki Niikura, et al.
Pageof 10